Active Ingredient: Nandrolone
For use in osteoporosis in post-menopausal women.
Established osteoporosis should have been diagnosed by the following parameters:
For this indication, competent medicine agencies globally authorize below treatments:
Intramuscular
50 - 50 mg
From 50 To 50 mg once every 21 day(s)
Post-menopausal women: 50mg every three weeks.
The duration of treatment depends on the clinical response and the possible occurrence of side-effects.
We would recommend that the effectiveness of therapy be monitored with the appropriate methods for osteoporosis on a 6-12 monthly basis.
It should be administered by deep intramuscular injection.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
